ישראל - עברית - Ministry of Health

teva israel ltd - reslizumab - תרכיז להכנת תמיסה לאינפוזיה - reslizumab 10 mg / 1 ml - reslizumab

ישראל - עברית - Ministry of Health

sanofi israel ltd - dupilumab - תמיסה להזרקה - dupilumab 150 mg/ml - dupilumab

ישראל - עברית - Ministry of Health

sanofi israel ltd - dupilumab - תמיסה להזרקה - dupilumab 175 mg/ml - dupilumab

ישראל - עברית - Ministry of Health

novartis israel ltd - omalizumab - אבקה וממס להכנת תמיסה להזרקה - omalizumab 150 mg/dose - omalizumab - omalizumab - xolair is indicated for adults and adolescents (12 years of age and above) with moderate to severe persistent asthma who have a positive skin test or in vitro reactivity to a perennial aeroallergen and whose symptoms are inadequately controlled with inhaled corticosteroids. xolair has been shown to decrease the incidence of asthma exacerbations in these patients. safety and efficacy have not been established in other allergic conditions.

ישראל - עברית - Ministry of Health

alexion pharma israel ltd - eculizumab - תרכיז להכנת תמיסה לאינפוזיה - eculizumab 10 mg/ml - eculizumab - eculizumab - soliris is indicated for the treatment of patients with: - paroxysmal nocturnal hemoglobinuria ( pnh ).- atypical hemolytic uremic syndrome (ahus).

ישראל - עברית - Ministry of Health

takeda israel ltd - vedolizumab - אבקה להכנת תמיסה מרוכזת לעירוי - vedolizumab 300 mg/vial - vedolizumab

ישראל - עברית - Ministry of Health

takeda israel ltd - vedolizumab - תמיסה להזרקה - vedolizumab 158.8 mg / 1 ml - vedolizumab

ישראל - עברית - Ministry of Health

roche pharmaceuticals (israel) ltd - ocrelizumab - תרכיז להכנת תמיסה לאינפוזיה - ocrelizumab 30 mg/ml - ocrelizumab

ישראל - עברית - Ministry of Health

glaxo smith kline (israel) ltd - neisseria meningitides group b strain nz98/254; neisseria meningitidis group b fhbp fusion protein; neisseria meningitidis group b nada protein; neisseria meningitidis group b nhba fusion protein - תרחיף להזרקה - neisseria meningitides group b strain nz98/254 25 mcg; neisseria meningitidis group b fhbp fusion protein 50 mcg; neisseria meningitidis group b nada protein 50 mcg; neisseria meningitidis group b nhba fusion protein 50 mcg - meningococcus b, outer membrane vesicle vaccine

ישראל - עברית - Ministry of Health

pfizer pharmaceuticals israel ltd - meningococcus b, multicomponent vaccine; meningococcus b, multicomponent vaccine - תרחיף להזרקה - meningococcus b, multicomponent vaccine 60 mcg; meningococcus b, multicomponent vaccine 60 mcg - meningococcus b, multicomponent vaccine